Efficacy and safety of 90Y ibritumomab tiuxetan (zevalin) radioimmunotherapy for non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of 90Y ibritumomab tiuxetan (zevalin) radioimmunotherapy for non-Hodgkin’s lymphoma

Published:2003-12 Issue: Volume:30 Page:11-16
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Witzig Thomas E

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference20 articles.

1. Radioimmunotherapy for lymphoma;Zelenetz;Curr Opin Oncol,1999

2. Expression of human B cell-associated antigens on leukemias and lymphomas;Anderson;Blood,1984

3. Recent advances in antigen-targeted therapy in non-Hodgkin’s lymphoma;Feuring-Buske;Ann Hematol,2000

4. Radioimmunotherapy of relapsed non-Hodgkin’s lymphoma with Zevalin, a 90Y-labeled anti-CD20 monoclonal antibody;Wiseman;Clin Cancer Res,1999

5. Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates;Johnson;Ann Hematol,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma;The Oncologist;2024-01-11

2. Theranostics in Hematooncology;Journal of Nuclear Medicine;2023-06-08

3. Nuclear Imaging of Endogenous Markers of Lymphocyte Response;Nuclear Medicine and Immunology;2021-11-25

4. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma;International Reviews of Immunology;2019-03-04

5. Targeted radiotherapy of pigmented melanoma with 131I-5-IPN;Journal of Experimental & Clinical Cancer Research;2018-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP